{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T17:21:58Z","timestamp":1777396918003,"version":"3.51.4"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Ministerio de Economia y Competitividad"},{"DOI":"10.13039\/501100002924","name":"FEDER","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/j.bcp.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,3,14]],"date-time":"2019-03-14T02:41:12Z","timestamp":1552531272000},"page":"214-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Fighting rheumatoid arthritis: Kv1.3 as a therapeutic target"],"prefix":"10.1016","volume":"165","author":[{"given":"Antonio","family":"Serrano-Albarr\u00e1s","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergi","family":"Cirera-Rocosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Sastre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Estadella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Felipe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2019.03.016_b0005","series-title":"The Autoimmune Diseases","author":"Davidson","year":"2014"},{"key":"10.1016\/j.bcp.2019.03.016_b0010","unstructured":"E. Goldmuntz, A.S. Penn, Autoimmune diseases. Office on Women\u2019s Health: U.S. Department of Health & Human Services; 2018 [updated May 22, 2018; cited 2018 November 8, 2018]; Available from: https:\/\/www.womenshealth.gov\/a-z-topics\/autoimmune-diseases."},{"issue":"5017","key":"10.1016\/j.bcp.2019.03.016_b0015","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1136\/bmj.1.5017.475","article-title":"Multiple sclerosis: a plea for a fresh outlook","volume":"1","author":"McAlpine","year":"1957","journal-title":"Br. Med. J."},{"key":"10.1016\/j.bcp.2019.03.016_b0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1136\/ard.20.4.363","article-title":"Interactions of rheumatoid factor with immune precipitate containing antibody of human origin","volume":"20","author":"Harboe","year":"1961","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.016_b0025","doi-asserted-by":"crossref","first-page":"130","DOI":"10.7326\/0003-4819-60-1-130","article-title":"Myasthenia gravis and auto-immune disease: review of the literature including a case report of the coexistence of myasthenia and systemic lupus erythematosus","volume":"60","author":"Piemme","year":"1964","journal-title":"Ann. Intern. Med."},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0030","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.4049\/jimmunol.106.4.1112","article-title":"Human anti-insulin antibodies","volume":"106","author":"Faulk","year":"1971","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0035","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000197178","article-title":"The immunopathology of coeliac disease","volume":"5","author":"Shiner","year":"1972","journal-title":"Digestion"},{"issue":"10","key":"10.1016\/j.bcp.2019.03.016_b0040","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/j.autrev.2012.02.001","article-title":"Updated assessment of the prevalence, spectrum and case definition of autoimmune disease","volume":"11","author":"Hayter","year":"2012","journal-title":"Autoimmun. Rev."},{"issue":"13","key":"10.1016\/j.bcp.2019.03.016_b0045","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1001\/jama.1957.02980130015004","article-title":"Chronic thyroiditis and autoimmunization","volume":"164","author":"Witebsky","year":"1957","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.bcp.2019.03.016_b0050","unstructured":"K. Murphy, C. Weaver, Janeway\u2019s Immunobiology. 8th ed. Science G, editor 2012."},{"issue":"6246","key":"10.1016\/j.bcp.2019.03.016_b0055","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/342183a0","article-title":"How some T cells escape tolerance induction","volume":"342","author":"Gammon","year":"1989","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.bcp.2019.03.016_b0060","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0092-8674(95)90348-8","article-title":"Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein","volume":"80","author":"Wucherpfennig","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bcp.2019.03.016_b0065","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2014.12.002","article-title":"Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: a critical review","volume":"57","author":"Maverakis","year":"2015","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0070","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12016-011-8285-8","article-title":"Hygiene hypothesis and autoimmune diseases","volume":"42","author":"Rook","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"8","key":"10.1016\/j.bcp.2019.03.016_b0075","first-page":"693","article-title":"Clinical features of familial multiple sclerosis in Spain","volume":"29","author":"Fernandez-Perez","year":"1999","journal-title":"Rev. Neurol."},{"issue":"50","key":"10.1016\/j.bcp.2019.03.016_b0080","first-page":"2785","article-title":"Genetic background of rheumatoid arthritis in connection with a family tree","volume":"142","author":"Nemes","year":"2001","journal-title":"Orvosi. Hetilap."},{"key":"10.1016\/j.bcp.2019.03.016_b0085","doi-asserted-by":"crossref","first-page":"4193538","DOI":"10.1155\/2016\/4193538","article-title":"The -174G\/C interleukin-6 gene promoter polymorphism as a genetic marker of differences in therapeutic response to methotrexate and leflunomide in rheumatoid arthritis","volume":"2016","author":"Ruiz-Padilla","year":"2016","journal-title":"Biomed. Res. Int."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.016_b0090","first-page":"515","article-title":"Biophysical and pharmacological aspects of K+ channels in T lymphocytes","volume":"34","author":"Panyi","year":"2005","journal-title":"Eur. Biophys. J.: EBJ"},{"issue":"6","key":"10.1016\/j.bcp.2019.03.016_b0095","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1177\/1073858405278016","article-title":"Potassium channels, memory T cells, and multiple sclerosis","volume":"11","author":"Beeton","year":"2005","journal-title":"The Neuroscientist"},{"issue":"31","key":"10.1016\/j.bcp.2019.03.016_b0100","doi-asserted-by":"crossref","first-page":"11094","DOI":"10.1073\/pnas.0501770102","article-title":"The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain","volume":"102","author":"Rus","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1\u20132","key":"10.1016\/j.bcp.2019.03.016_b0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.imlet.2009.12.015","article-title":"Ion channels in T lymphocytes: an update on facts, mechanisms and therapeutic targeting in autoimmune diseases","volume":"130","author":"Varga","year":"2010","journal-title":"Immunol. Lett."},{"issue":"6754","key":"10.1016\/j.bcp.2019.03.016_b0110","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/44385","article-title":"Two subsets of memory T lymphocytes with distinct homing potentials and effector functions","volume":"401","author":"Sallusto","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2019.03.016_b0115","doi-asserted-by":"crossref","first-page":"17414","DOI":"10.1073\/pnas.0605136103","article-title":"Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases","volume":"103","author":"Beeton","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0120","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1600-065X.2009.00816.x","article-title":"The functional network of ion channels in T lymphocytes","volume":"231","author":"Cahalan","year":"2009","journal-title":"Immunol. Rev."},{"issue":"24","key":"10.1016\/j.bcp.2019.03.016_b0125","doi-asserted-by":"crossref","first-page":"13942","DOI":"10.1073\/pnas.241497298","article-title":"Selective blockade of T lymphocyte K(+) channels ameliorates experimental autoimmune encephalomyelitis, a model for multiple sclerosis","volume":"98","author":"Beeton","year":"2001","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2019.03.016_b0130","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1124\/jpet.112.191890","article-title":"Durable pharmacological responses from the peptide ShK-186, a specific Kv1.3 channel inhibitor that suppresses T cell mediators of autoimmune disease","volume":"342","author":"Tarcha","year":"2012","journal-title":"J. Pharmacol. Experimental Therapeutics"},{"issue":"10","key":"10.1016\/j.bcp.2019.03.016_b0135","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/cns.12848","article-title":"A Kv1.3 channel-specific blocker alleviates neurological impairment through inhibiting T-cell activation in experimental autoimmune encephalomyelitis","volume":"24","author":"Yuan","year":"2018","journal-title":"CNS Neurosci. Therapeutics"},{"issue":"23","key":"10.1016\/j.bcp.2019.03.016_b0140","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.016_b0145","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.bcp.2019.03.016_b0150","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1002\/art.39299","article-title":"IgG subclass specificity discriminates restricted IgM rheumatoid factor responses from more mature anti-citrullinated protein antibody-associated or isotype-switched IgA responses","volume":"67","author":"Falkenburg","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0155","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.pain.2008.01.008","article-title":"The effects of anxiety and depression on weekly pain in women with arthritis","volume":"138","author":"Smith","year":"2008","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0160","doi-asserted-by":"crossref","first-page":"202","DOI":"10.7326\/0003-4819-71-1-202","article-title":"Immunosuppressive drugs in rheumatoid arthritis","volume":"71","author":"Baum","year":"1969","journal-title":"Ann. Intern. Med."},{"issue":"3563","key":"10.1016\/j.bcp.2019.03.016_b0165","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1126\/science.140.3563.186","article-title":"Methotrexate: suppression of experimental allergic encephalomyelitis","volume":"140","author":"Brandriss","year":"1963","journal-title":"Science"},{"issue":"21","key":"10.1016\/j.bcp.2019.03.016_b0170","doi-asserted-by":"crossref","first-page":"13481","DOI":"10.1073\/pnas.172501499","article-title":"Interaction of dihydrofolate reductase with methotrexate: ensemble and single-molecule kinetics","volume":"99","author":"Rajagopalan","year":"2002","journal-title":"PNAS"},{"issue":"5","key":"10.1016\/j.bcp.2019.03.016_b0175","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/stem.170314","article-title":"The molecular perspective: methotrexate","volume":"17","author":"Goodsell","year":"1999","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0180","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0002-9378(58)90571-4","article-title":"Methotrexate therapy of metastatic choriocarcinoma","volume":"75","author":"Holland","year":"1958","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.bcp.2019.03.016_b0185","first-page":"29","article-title":"Continuous arterial infusion of methotrexate with intermittent, intramuscular citrovorum factor therapy in head and neck cancer","volume":"42","author":"Sullivan","year":"1961","journal-title":"Trans. Pacific Coast Oto-Ophthalmol. Soc. Annu. Meet."},{"key":"10.1016\/j.bcp.2019.03.016_b0190","first-page":"1","article-title":"The influence of race and sex on the side effect profile of methotrexate in the treatment of uveitis","author":"LaMattina","year":"2018","journal-title":"Ocular Immunol. Inflamm."},{"issue":"5 Suppl. 61","key":"10.1016\/j.bcp.2019.03.016_b0195","first-page":"S80","article-title":"Use of methotrexate in young patients with respect to the reproductive system","volume":"28","author":"Gromnica-Ihle","year":"2010","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.bcp.2019.03.016_b0200","unstructured":"WHO Model List of Essential Medicines (20th List). World Health Organization, 2017."},{"key":"10.1016\/j.bcp.2019.03.016_b0205","unstructured":"Mayo Clinic\u2019s web page. 2019 [cited 2019 05-Mar-2019]; Available from: https:\/\/www.mayoclinic.org\/."},{"issue":"41","key":"10.1016\/j.bcp.2019.03.016_b0210","doi-asserted-by":"crossref","first-page":"e12658","DOI":"10.1097\/MD.0000000000012658","article-title":"Use of steroid and nonsteroidal anti-inflammatories in the treatment of rheumatoid arthritis: systematic review protocol","volume":"97","author":"Del Grossi Moura","year":"2018","journal-title":"Medicine"},{"issue":"18","key":"10.1016\/j.bcp.2019.03.016_b0215","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.296.18.2203-a","article-title":"Risk of serious infections and malignancies with anti-TNF antibody therapy in rheumatoid arthritis","volume":"296","author":"Hochman","year":"2006","journal-title":"Jama"},{"issue":"9","key":"10.1016\/j.bcp.2019.03.016_b0220","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1002\/art.34468","article-title":"Progressive multifocal leukoencephalopathy associated with immunosuppressive therapy in rheumatic diseases: evolving role of biologic therapies","volume":"64","author":"Molloy","year":"2012","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.016_b0225","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1136\/annrheumdis-2013-204573","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update","volume":"73","author":"Smolen","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.bcp.2019.03.016_b0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1113\/jphysiol.1985.sp015548","article-title":"A voltage-gated potassium channel in human T lymphocytes","volume":"358","author":"Cahalan","year":"1985","journal-title":"J. Physiol."},{"issue":"16","key":"10.1016\/j.bcp.2019.03.016_b0235","doi-asserted-by":"crossref","first-page":"3205","DOI":"10.1002\/cne.22393","article-title":"Localization of Kv1.3 channels in presynaptic terminals of brainstem auditory neurons.","volume":"518","author":"Gazula","year":"2010","journal-title":"J. Comp. Neurol."},{"issue":"21","key":"10.1016\/j.bcp.2019.03.016_b0240","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1007\/s00018-018-2851-7","article-title":"Caveolar targeting links Kv1.3 with the insulin-dependent adipocyte physiology","volume":"75","author":"Perez-Verdaguer","year":"2018","journal-title":"Cell. Mol. Life Sci.: CMLS"},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0245","doi-asserted-by":"crossref","first-page":"C965","DOI":"10.1152\/ajpcell.00074.2003","article-title":"A voltage-gated K(+) current in renal inner medullary collecting duct cells","volume":"286","author":"Escobar","year":"2004","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.016_b0250","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1073\/pnas.0307421100","article-title":"Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells","volume":"101","author":"Panyi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.bcp.2019.03.016_b0255","doi-asserted-by":"crossref","first-page":"10082","DOI":"10.1038\/srep10082","article-title":"The T cell receptor resides in ordered plasma membrane nanodomains that aggregate upon patching of the receptor","volume":"5","author":"Dinic","year":"2015","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0260","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00424-007-0208-4","article-title":"Methyl-beta-cyclodextrin reversibly alters the gating of lipid rafts-associated Kv1.3 channels in Jurkat T lymphocytes.","volume":"454","author":"Pottosin","year":"2007","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"key":"10.1016\/j.bcp.2019.03.016_b0265","doi-asserted-by":"crossref","first-page":"22453","DOI":"10.1038\/srep22453","article-title":"Caveolin interaction governs Kv1.3 lipid raft targeting","volume":"6","author":"Perez-Verdaguer","year":"2016","journal-title":"Scientific Rep."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.016_b0270","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00424-002-0974-y","article-title":"Cholesterol modifies the gating of Kv1.3 in human T lymphocytes","volume":"445","author":"Hajdu","year":"2003","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1085\/jgp.200910334","article-title":"Immunomodulation of voltage-dependent K+ channels in macrophages: molecular and biophysical consequences","volume":"135","author":"Villalonga","year":"2010","journal-title":"J. General Physiol."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0280","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00424-003-1148-2","article-title":"Effect of dexamethasone on voltage-gated K+ channels in Jurkat T-lymphocytes","volume":"447","author":"Lampert","year":"2003","journal-title":"Pflugers Archiv: Eur. J. Physiol."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.016_b0285","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.bcp.2010.05.012","article-title":"Immunomodulatory effects of diclofenac in leukocytes through the targeting of Kv1.3 voltage-dependent potassium channels","volume":"80","author":"Villalonga","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"11","key":"10.1016\/j.bcp.2019.03.016_b0290","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.4049\/jimmunol.158.11.5120","article-title":"Blockade of the voltage-gated potassium channel Kv1.3 inhibits immune responses in vivo","volume":"158","author":"Koo","year":"1997","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2019.03.016_b0295","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.4049\/jimmunol.179.7.4563","article-title":"Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes","volume":"179","author":"Hu","year":"2007","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.016_b0300","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1124\/mol.105.015669","article-title":"Design of PAP-1, a selective small molecule Kv1.3 blocker, for the suppression of effector memory T cells in autoimmune diseases","volume":"68","author":"Schmitz","year":"2005","journal-title":"Mol. Pharmacol."},{"issue":"47","key":"10.1016\/j.bcp.2019.03.016_b0305","doi-asserted-by":"crossref","first-page":"46307","DOI":"10.1074\/jbc.M304388200","article-title":"Differential voltage-dependent K+ channel responses during proliferation and activation in macrophages","volume":"278","author":"Vicente","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"49","key":"10.1016\/j.bcp.2019.03.016_b0310","doi-asserted-by":"crossref","first-page":"37675","DOI":"10.1074\/jbc.M605617200","article-title":"Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages","volume":"281","author":"Vicente","year":"2006","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0315","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.bbrc.2006.11.120","article-title":"Kv1.3\/Kv1.5 heteromeric channels compromise pharmacological responses in macrophages","volume":"352","author":"Villalonga","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"Pt 20","key":"10.1016\/j.bcp.2019.03.016_b0320","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1242\/jcs.056689","article-title":"KCNE4 suppresses Kv1.3 currents by modulating trafficking, surface expression and channel gating","volume":"122","author":"Sole","year":"2009","journal-title":"J. Cell Sci."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0325","doi-asserted-by":"crossref","first-page":"85","DOI":"10.4161\/chan.23258","article-title":"KCNE gene expression is dependent on the proliferation and mode of activation of leukocytes","volume":"7","author":"Sole","year":"2013","journal-title":"Channels (Austin)"},{"issue":"Pt 24","key":"10.1016\/j.bcp.2019.03.016_b0330","first-page":"5681","article-title":"A non-canonical di-acidic signal at the C-terminus of Kv1.3 determines anterograde trafficking and surface expression","volume":"126","author":"Martinez-Marmol","year":"2013","journal-title":"J. Cell Sci."},{"issue":"22","key":"10.1016\/j.bcp.2019.03.016_b0335","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1242\/jcs.191650","article-title":"The C-terminal domain of Kv1.3 regulates functional interactions with the KCNE4 subunit","volume":"129","author":"Sole","year":"2016","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.bcp.2019.03.016_b0340","doi-asserted-by":"crossref","first-page":"45310","DOI":"10.1038\/srep45310","article-title":"Mechanism of functional interaction between potassium channel Kv1.3 and sodium channel NavBeta1 subunit","volume":"7","author":"Kubota","year":"2017","journal-title":"Scientific Rep."},{"issue":"7","key":"10.1016\/j.bcp.2019.03.016_b0345","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/0028-3908(96)00094-9","article-title":"Inhibition by nystatin of Kv1.3 channels expressed in Chinese hamster ovary cells","volume":"35","author":"Hahn","year":"1996","journal-title":"Neuropharmacology"},{"issue":"10","key":"10.1016\/j.bcp.2019.03.016_b0350","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1096\/fj.15-274787","article-title":"Human alpha-defensins are immune-related Kv1.3 channel inhibitors: new support for their roles in adaptive immunity","volume":"29","author":"Xie","year":"2015","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0355","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/toxins7010034","article-title":"Plectasin, first animal toxin-like fungal defensin blocking potassium channels through recognizing channel pore region","volume":"7","author":"Xiang","year":"2015","journal-title":"Toxins"},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0360","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1085\/jgp.201310986","article-title":"Tuning voltage-gated channel activity and cellular excitability with a sphingomyelinase","volume":"142","author":"Combs","year":"2013","journal-title":"J. Gen. Physiol."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.016_b0365","doi-asserted-by":"crossref","first-page":"6451","DOI":"10.1074\/jbc.M112.421495","article-title":"Intracellular trafficking of the KV1.3 potassium channel is regulated by the prodomain of a matrix metalloprotease","volume":"288","author":"Nguyen","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"16","key":"10.1016\/j.bcp.2019.03.016_b0370","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1073\/pnas.0400782101","article-title":"A gene atlas of the mouse and human protein-encoding transcriptomes","volume":"101","author":"Su","year":"2004","journal-title":"PNAS"},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0375","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.bbrc.2014.07.003","article-title":"Down-regulation of K(+) channels by human parvovirus B19 capsid protein VP1","volume":"450","author":"Ahmed","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bcp.2019.03.016_b0380","unstructured":"S7B: The Non-Clinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals, (2005)."},{"issue":"41","key":"10.1016\/j.bcp.2019.03.016_b0385","doi-asserted-by":"crossref","first-page":"39443","DOI":"10.1074\/jbc.M304879200","article-title":"Compensatory anion currents in Kv1.3 channel-deficient thymocytes","volume":"278","author":"Koni","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.bcp.2019.03.016_b0390","doi-asserted-by":"crossref","first-page":"5877","DOI":"10.4049\/jimmunol.1103095","article-title":"Kv1.3 deletion biases T cells toward an immunoregulatory phenotype and renders mice resistant to autoimmune encephalomyelitis","volume":"188","author":"Gocke","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0395","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.4049\/jimmunol.1403024","article-title":"Antigenic stimulation of Kv1.3-deficient th cells gives rise to a population of Foxp3-independent T cells with suppressive properties","volume":"195","author":"Grishkan","year":"2015","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.bcp.2019.03.016_b0400","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/glia.23457","article-title":"Jin LW, Maezawa I. The voltage-gated potassium channel Kv1.3 is required for microglial pro-inflammatory activation in vivo","volume":"66","author":"Di Lucente","year":"2018","journal-title":"Glia"},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0405","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1136\/annrheumdis-2013-204223","article-title":"Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)","volume":"73","author":"Dougados","year":"2014","journal-title":"Ann. Rheum. Dis."},{"issue":"8","key":"10.1016\/j.bcp.2019.03.016_b0410","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/ced.12097","article-title":"Kv1.3 blockers ameliorate allergic contact dermatitis by preferentially suppressing effector memory T cells in a rat model","volume":"38","author":"Ueyama","year":"2013","journal-title":"Clin. Exp. Dermatol."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.016_b0415","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0896-6273(03)00844-4","article-title":"Kv1.3 channel gene-targeted deletion produces \u201cSuper-Smeller Mice\u201d with altered glomeruli, interacting scaffolding proteins, and biophysics","volume":"41","author":"Fadool","year":"2004","journal-title":"Neuron"},{"issue":"8","key":"10.1016\/j.bcp.2019.03.016_b0420","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1111\/j.1365-2826.2012.02314.x","article-title":"Diet-induced obesity resistance of Kv1.3-\/- mice is olfactory bulb dependent","volume":"24","author":"Tucker","year":"2012","journal-title":"J. Neuroendocrinol."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.016_b0425","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.physbeh.2005.08.024","article-title":"Electrophysiological and behavioral phenotype of insulin receptor defective mice","volume":"86","author":"Das","year":"2005","journal-title":"Physiol. Behav."},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0430","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0166-4328(00)00356-9","article-title":"Kaliotoxin, a Kv1.1 and Kv1.3 channel blocker, improves associative learning in rats","volume":"120","author":"Kourrich","year":"2001","journal-title":"Behav. Brain Res."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0435","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/brain\/awx346","article-title":"Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer's disease: preclinical proof of concept","volume":"141","author":"Maezawa","year":"2018","journal-title":"Brain"},{"issue":"29","key":"10.1016\/j.bcp.2019.03.016_b0440","doi-asserted-by":"crossref","first-page":"20971","DOI":"10.1016\/S0021-9258(19)36784-5","article-title":"The Shaw-related potassium channel gene, Kv3.1, on human chromosome 11, encodes the type l K+ channel in T cells","volume":"267","author":"Grissmer","year":"1992","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.bcp.2019.03.016_b0445","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1084\/jem.20020381","article-title":"Modulation of Kv channel expression and function by TCR and costimulatory signals during peripheral CD4(+) lymphocyte differentiation","volume":"196","author":"Liu","year":"2002","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0450","doi-asserted-by":"crossref","first-page":"610","DOI":"10.4049\/jimmunol.151.2.610","article-title":"Lack of voltage sensitive potassium channels and generation of membrane potential by sodium potassium ATPase in murine T lymphocytes","volume":"151","author":"Ishida","year":"1993","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.bcp.2019.03.016_b0455","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/nrn1988","article-title":"Non-conducting functions of voltage-gated ion channels","volume":"7","author":"Kaczmarek","year":"2006","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.016_b0460","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1161\/ATVBAHA.111.242727","article-title":"Kv1.3 channels can modulate cell proliferation during phenotypic switch by an ion-flux independent mechanism","volume":"32","author":"Cidad","year":"2012","journal-title":"Arteriosclerosis Thrombosis Vasc. Biol."},{"issue":"18","key":"10.1016\/j.bcp.2019.03.016_b0465","doi-asserted-by":"crossref","first-page":"12623-","DOI":"10.1074\/jbc.M113.517037","article-title":"Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma","volume":"289","author":"Koshy","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"25","key":"10.1016\/j.bcp.2019.03.016_b0470","doi-asserted-by":"crossref","first-page":"18866","DOI":"10.1016\/S0021-9258(17)46707-X","article-title":"Purification, characterization, and biosynthesis of margatoxin, a component of Centruroides margaritatus venom that selectively inhibits voltage-dependent potassium channels","volume":"268","author":"Garcia-Calvo","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.bcp.2019.03.016_b0475","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-3011.1995.tb01068.x","article-title":"Chemical synthesis and characterization of ShK toxin: a potent potassium channel inhibitor from a sea anemone","volume":"46","author":"Pennington","year":"1995","journal-title":"Int. J. Pept. Protein Res."},{"key":"10.1016\/j.bcp.2019.03.016_b0480","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jaut.2014.07.003","article-title":"Raychaudhuri SP. Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis\u2013xenograft model","volume":"55","author":"Kundu-Raychaudhuri","year":"2014","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.bcp.2019.03.016_b0485","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1124\/mol.65.6.1364","article-title":"Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators","volume":"65","author":"Vennekamp","year":"2004","journal-title":"Mol. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2019.03.016_b0490","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180762","article-title":"Safety and pharmacodynamics of dalazatide, a Kv1.3 channel inhibitor, in the treatment of plaque psoriasis: a randomized phase 1b trial","volume":"12","author":"Tarcha","year":"2017","journal-title":"PloS One"},{"issue":"49","key":"10.1016\/j.bcp.2019.03.016_b0495","doi-asserted-by":"crossref","first-page":"32697","DOI":"10.1074\/jbc.273.49.32697","article-title":"ShK-Dap22, a potent Kv1.3-specific immunosuppressive polypeptide","volume":"273","author":"Kalman","year":"1998","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bcp.2019.03.016_b0500","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.toxicon.2011.07.016","article-title":"Development of a sea anemone toxin as an immunomodulator for therapy of autoimmune diseases","volume":"59","author":"Chi","year":"2012","journal-title":"Toxicon"},{"key":"10.1016\/j.bcp.2019.03.016_b0505","first-page":"27","article-title":"Poster: Kv1.3 expression on effector memory T-cells in sporadic inclusion body myositis: Potential for targeted immunotherapy with Dalazatide","author":"Mozaffar","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.bcp.2019.03.016_b0510","article-title":"Kv1.3 expression on urinary leukocytes in lupus nephritis: potential for targeted immunotherapy","author":"Stevens","year":"2017","journal-title":"Pediatric Rheumatol. Symposium Houston"},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0515","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11095-014-1485-1","article-title":"Enhancing the buccal mucosal delivery of peptide and protein therapeutics","volume":"32","author":"Caon","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.bcp.2019.03.016_b0520","doi-asserted-by":"crossref","first-page":"18397","DOI":"10.1038\/srep18397","article-title":"An engineered scorpion toxin analogue with improved Kv1.3 selectivity displays reduced conformational flexibility","volume":"5","author":"Bartok","year":"2015","journal-title":"Scientific Rep."},{"issue":"33","key":"10.1016\/j.bcp.2019.03.016_b0525","doi-asserted-by":"crossref","first-page":"22704","DOI":"10.1074\/jbc.M114.568642","article-title":"Targeting the ion channel Kv1.3 with scorpion venom peptides engineered for potency, selectivity, and half-life","volume":"289","author":"Edwards","year":"2014","journal-title":"J. Biol. Chem."},{"issue":"41","key":"10.1016\/j.bcp.2019.03.016_b0530","doi-asserted-by":"crossref","first-page":"11501","DOI":"10.1073\/pnas.1612803113","article-title":"Rational design of a Kv1.3 channel-blocking antibody as a selective immunosuppressant","volume":"113","author":"Wang","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"2","key":"10.1016\/j.bcp.2019.03.016_b0535","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.xphs.2015.10.025","article-title":"Pulmonary delivery of the Kv1.3-blocking peptide HsTX1[R14A] for the treatment of autoimmune diseases","volume":"105","author":"Jin","year":"2016","journal-title":"J. Pharm. Sci."},{"issue":"13","key":"10.1016\/j.bcp.2019.03.016_b0540","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1074\/jbc.M708223200","article-title":"Kv1.5 association modifies Kv1.3 traffic and membrane localization","volume":"283","author":"Vicente","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.bcp.2019.03.016_b0545","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.4049\/jimmunol.174.8.4736","article-title":"Pattern of Kv beta subunit expression in macrophages depends upon proliferation and the mode of activation","volume":"174","author":"Vicente","year":"2005","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.bcp.2019.03.016_b0550","doi-asserted-by":"crossref","first-page":"708","DOI":"10.7150\/thno.30418","article-title":"Enhanced therapeutic effect of RGD-modified polymeric micelles loaded with low-dose methotrexate and nimesulide on rheumatoid arthritis","volume":"9","author":"Wang","year":"2019","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.bcp.2019.03.016_b0555","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13075-019-1819-9","article-title":"Combining naproxen and a dual amylin and calcitonin receptor agonist improves pain and structural outcomes in the collagen-induced arthritis rat model","volume":"21","author":"Katri","year":"2019","journal-title":"Arthritis Res. Therapy"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219301029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:09:40Z","timestamp":1757768980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219301029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":111,"alternative-id":["S0006295219301029"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.03.016","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fighting rheumatoid arthritis: Kv1.3 as a therapeutic target","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}